Nov 07, 2018
SI-BONE To Report Third Quarter Financial Results on November 29, 2018
Oct 19, 2018
SI-BONE Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares
Oct 16, 2018
SI-BONE Announces Pricing of Initial Public Offering
Oct 03, 2018
SI-BONE, Inc. Announces that NICE, the UK National Institute for Health and Care Excellence, Published Medical Technology Guidance Finding that the Evidence Supports Treatment of Sacroiliac Joint Pain with the iFuse Implant System®
Sep 20, 2018
SI-BONE Files Registration Statement for Proposed Initial Public Offering
Aug 27, 2018
SI-BONE, Inc. Announces France's National Healthcare System Establishes Exclusive Positive Coverage for the Triangular iFuse Implant System® for MIS SI Joint Fusion
Apr 09, 2018
SI-BONE, Inc. Announces Publication of 3-Year Long-term Prospective Outcomes Including Randomized Controlled Trial Data on 103 Patients Post SI Joint Fusion with Triangular iFuse Implant System®
Apr 09, 2018
SI-BONE, Inc. Hosts ISASS 2018 Sacroiliac Joint Workshop led by David Polly, MD, Bengt Sturesson, MD, Peter Whang, MD and Brad Duhon, MD
Jan 02, 2018
SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion
Oct 23, 2017
SI-BONE's New iFuse-Navigation(TM) Set* and iFuse-3D(TM) Fenestrated SI Joint Fusion Implant to be Featured at the 2017 North American Spine Society Annual Meeting
Oct 09, 2017
SI-BONE, Inc. Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure(TM) for Minimally Invasive SI Joint Fusion
Sep 25, 2017
SI-BONE, Inc. Announces Publication of iMIA - a 2nd Multicenter Randomized Controlled Trial of the iFuse Implant System® vs Conservative Care
Aug 23, 2017
SI-BONE, Inc. Announces Highmark, Inc., 4th Largest Blue Cross Blue Shield Plan and 10th Largest U.S. Commercial Payor, Establishes Positive Coverage Policy for Minimally Invasive Sacroiliac Joint Fusion Exclusively for the iFuse Implant System®
Aug 09, 2017
SI-BONE, Inc. Announces Publication of a Level I Study Demonstrating Strong Clinical Prediction for the Diagnosis of SI Joint Dysfunction
Aug 02, 2017
SI-BONE, Inc. Announces Minimally Invasive SI Joint Fusion using the iFuse Implant System® Maintains Exclusive Positive Coverage with Blue Cross and Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas
Jun 13, 2017
SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D(TM) Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System®
Jun 12, 2017
SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion